Investing Ideas
/
Hungarian Pharmaceuticals & Biotech Healthy potentially undervalued

Hungarian Pharmaceuticals & Biotech Healthy potentially undervalued

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

0 new

Companies which are potentially undervalued and in an acceptable financial position.

1 companies

Gedeon Richter

Market Cap: Ft2.2t

Researches, develops, manufactures, markets, and sells pharmaceutical products.

RICHTER

Ft12,090.00

-0.8%

18.5%